Pacific View Asset Management’s Blueprint Medicines BPMC Stock Holding History

Pacific View Asset Management’s Portfolio BPMC Stock Details BPMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-4,925	Closed	-$463K	–	13
2019 Q2	$463K	Buy	4,925 +1	+0%	+$83	0.5%	43
2019 Q1	$395K	Sell	4,924 -1	-0%	-$74	0.41%	44
2018 Q4	$264K	Buy	4,925 +193	+4%	+$11.7K	0.31%	51
2018 Q3	$370K	Sell	4,732 -98	-2%	-$6.81K	0.29%	73
2018 Q2	$307K	Buy	4,830 +1,034	+27%	+$82.3K	0.24%	83
2018 Q1	$347K	Buy	+3,796	New	+$327K	0.26%	76

Other funds holding BPMC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Pacific View Asset Management's BPMC Position: Q3 2019 in Review

Pacific View Asset Management sold out of Blueprint Medicines (BPMC) in Q3 2019, closing a stake of 4,925 shares — an estimated $463K sold.

Pacific View Asset Management first reported a position in BPMC in Q1 2018 and held it in 6 quarters. The position peaked at $463K in Q2 2019. 219 funds tracked by Wall St. Rank hold BPMC as of Q3 2019.

Pacific View Asset Management reported no remaining Blueprint Medicines position as of Q3 2019 after selling out during the quarter.
Pacific View Asset Management sold 4,925 Blueprint Medicines shares in Q3 2019, an estimated $463K.
Pacific View Asset Management first reported a position in Blueprint Medicines in Q1 2018 and held it in 6 quarters.
Pacific View Asset Management's Blueprint Medicines position peaked at $463K in Q2 2019.
219 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2019.

Based on Pacific View Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.